BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2414175)

  • 1. [Donor selection for the production of factor XIII preparations].
    Uteg KH; Tausendfreund K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibilities to elevate the factor VIII yield].
    Uteg KH; Tausendfreund K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):153-69. PubMed ID: 2439416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis for the preparation of HIV free cryoprecipitate.
    Tardtong P; Chuansumrit A; Stabanswadigan S; Chiewsilp P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():195-7. PubMed ID: 7886572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency of mechanical plasmapheresis].
    Matthes G; Pawlow I; Richter E
    Beitr Infusionsther; 1991; 28():56-64. PubMed ID: 1725661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of factor VIII:C levels in blood donors.
    Carlebjörk G; Blombäck M; Blomstedt M; Akerblom O
    Vox Sang; 1986; 51(4):306-9. PubMed ID: 3099471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups.
    Jeremic M; Weisert O; Gedde-Dahl TW
    Scand J Clin Lab Invest; 1976 Sep; 36(5):461-6. PubMed ID: 981956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extensive study of donor plasmapheresis using a membrane method by the special study group of the Japanese Red Cross Society.
    Ikeda H; Tomono T; Sakai E; Endo N; Yokoyama S; Ogawa M; Shiraki H; Kameko S; Sekiguchi S
    Prog Clin Biol Res; 1990; 337():503-6. PubMed ID: 2112757
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative protein chemistry studies on Factor VIII concentrates].
    Kienast K; Trobisch H
    Arzneimittelforschung; 1984; 34(8):895-900. PubMed ID: 6437415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subcutaneous administration of desmopressin to plasma donors: a controlled study].
    Palacios S; Zuazu I; Candela MJ; Rivera J; Vicente V
    Med Clin (Barc); 1995 Oct; 105(14):525-7. PubMed ID: 8523926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease activity: assessment by factor VIII coagulation proteins.
    Zielen S; Bender SW; Kreuz W; Posselt HG; Solem E; Scharrer I
    J Pediatr Gastroenterol Nutr; 1985 Oct; 4(5):730-4. PubMed ID: 3930684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 'single donor' factor VIII from plasma exchange donation.
    McLeod BC; Scott JP
    JAMA; 1984 Nov; 252(19):2726-9. PubMed ID: 6436520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of concentrated blood derivatives of factor VIII].
    Baklaja R; Miletić V; Stajić M; Cvetković V; Grozdanić V
    Bilt Hematol Transfuz; 1984; 12(2):91-103. PubMed ID: 6441567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent regeneration of plasma proteins after donor plasmapheresis.
    Matthes G; Pawlow I; Ziemer S
    Beitr Infusionsther; 1992; 30():186-9. PubMed ID: 1284703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.